24 May 2013
Keywords: ranbaxy, gains, final, fda, approval, quinapril, hctz
Article | 09 March 2009
India-based generics major Ranbaxy Laboratories says its US subsidiary
has received approval from the Food and Drug Administration to
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 March 2009
23 May 2013
© 2013 thepharmaletter.com